Efficacy of Amicar for Children Having Craniofacial Surgery
Running, not enrolling · Phase 2 · Has a placebo group
Conditions studied: Craniosynostosis
In brief
The purpose of this study is to determine whether Amicar (ε-aminocaproic acid) is effective in reducing blood loss in children undergoing craniofacial reconstruction surgery. The investigators hypothesize that Amicar will decrease intraoperative blood loss and decrease the need for perioperative blood product administration in children undergoing craniofacial surgery.
Key facts
- Study ID
- NCT02229968
- Run by
- Children's National Research Institute
- People needed
- 22
- Starts
- 2014-10-01
- Expected to finish
- 2028-03-01
- Last updated by the study team
- 2026-04-07
Who can join
Age: 0 and older, up to 3. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Any child diagnosed with craniosynostosis in need of surgical repair
- Males and females between the ages of 2 - 36 months (minorities will be included)
- Surgical procedure involving complex craniofacial reconstruction and craniotomy
- Written informed consent from parent/guardian
You may not qualify if…
- Subjects with known or suspected hypersensitivity reaction to Amicar or history of prior Amicar exposure
- Presence or prior history of a known coagulation disorder or hypercoagulable state
- Preoperative laboratory values that indicate clinically significant hematologic disease (hemoglobin, platelet count, prothrombin time, or partial thromboplastin time outside of normal range)
- Subjects who are on anticoagulant therapy (Coumadin, heparin, aspirin, etc.)
- Subjects with a prior history of a thrombotic event
- History of renal malformation
- Presence of hematuria
- History of abnormal renal function - serum creatinine or blood urea nitrogen (BUN) value greater than 1.5 times the upper limit of the normal range
- Craniofacial reconstruction surgery performed in conjunction with an additional surgical procedure associated with blood loss
- Subjects who have been previously enrolled in this protocol may not be enrolled again
Where it is running
- Vanderbilt University Medical Center — Nashville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.